| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Cusack Catherine is a Director at SBRA. Recent filings cover 5 purchases and 0 sales. Those positions are worth an estimated $1.5M at current prices.
Our model assigns Cusack Catherine a middling insider score of 61/100, based on 4 past trades. Over a 12-month horizon, 75.0% of those trades were profitable, with an average 12-month return of +14.2%.
Cusack Catherine's largest disclosed position is in SBRA as Director, worth about $1.5M. Net of sales, the recent Form 4 record there shows accumulation of 12,500 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 24, 2025 | SBRA Sabra Health Care Reit, Inc. | Director | Buy | 2,500 | $16.13 | $40,315.00 | +2.1% | +10.8% | +29.2% | |
| May 22, 2024 | SBRA Sabra Health Care Reit, Inc. | Director | Buy | 7,000 | $14.43 | $101,010.00 | +17.8% | +13.8% | +19.3% | |
| May 13, 2021 | SBRA Sabra Health Care Reit, Inc. | Director | Buy | 2,000 | $17.19 | $34,380.00 | +51.4% | +0.8% | -17.3% | |
| Mar 2, 2021 | SBRA Sabra Health Care Reit, Inc. | Director | Buy | 1,000 | $17.34 | $17,340.00 | +34.6% | - | - |